These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11108186)

  • 1. Evaluation of toxicokinetic variables and arthropathic changes in juvenile rabbits after oral administration of an investigational fluoroquinolone, PD 117596.
    Johnson RJ; Black WD; Sigler RE; Baragi VM; Gough AW
    Am J Vet Res; 2000 Nov; 61(11):1396-402. PubMed ID: 11108186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolone arthropathy in immature rabbits treated with the fluoroquinolone, PD 117596.
    Gough A; Johnson R; Campbell E; Hall L; Tylor J; Carpenter A; Black W; Basrur PK; Baragi VM; Sigler R; Metz A
    Exp Toxicol Pathol; 1996 Jun; 48(4):225-32. PubMed ID: 8811288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondrotoxicity and toxicokinetics of novel quinolone antibacterial agents DC-159a and DX-619 in juvenile rats.
    Goto K; Yabe K; Suzuki T; Jindo T; Sanbuissho A
    Toxicology; 2010 Oct; 276(2):122-7. PubMed ID: 20688128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-arthropathic dose and its disposition following repeated oral administration of ofloxacin, a new quinolone antimicrobial agent, to juvenile dogs.
    Yabe K; Murakami Y; Nishida S; Sekiguchi M; Furuham K; Goryo M; Okada K
    J Vet Med Sci; 2001 Aug; 63(8):867-72. PubMed ID: 11558541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
    Nagai A; Miyazaki M; Morita T; Furubo S; Kizawa K; Fukumoto H; Sanzen T; Hayakawa H; Kawamura Y
    J Toxicol Sci; 2002 Aug; 27(3):219-28. PubMed ID: 12238145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative arthropathy of fluoroquinolones in dogs.
    Takizawa T; Hashimoto K; Minami T; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jun; 18(6):392-9. PubMed ID: 10413244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.
    Stahlmann R; Zippel U; Förster C; Schwabe R; Shakibaei M; Merker HJ; Borner K
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1470-5. PubMed ID: 9624496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olamufloxacin. Hokuriku Seiyaku.
    Jiraskova N
    Curr Opin Investig Drugs; 2000 Sep; 1(1):31-4. PubMed ID: 11249592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of enrofloxacin in rabbits.
    Broome RL; Brooks DL; Babish JG; Copeland DD; Conzelman GM
    Am J Vet Res; 1991 Nov; 52(11):1835-41. PubMed ID: 1664673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals.
    Machida M; Kusajima H; Aijima H; Maeda A; Ishida R; Uchida H
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):403-12. PubMed ID: 2237915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo.
    Kato M; Takada S; Ogawara S; Takayama S
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1979-83. PubMed ID: 8540702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A 4-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 4-week recovery test].
    Oda S; Ide M; Tamura K; Nagatani M; Shindo Y; Iwakura K; Sumi N
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():71-88. PubMed ID: 8709170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats.
    Kato M; Takada S; Kashida Y; Nomura M
    Toxicol Pathol; 1995; 23(3):385-92. PubMed ID: 7659960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral glucosamine hydrochloride and mucopolysaccharide protein in a rabbit model of osteoarthritis.
    Jeong DH; Ullah HMA; Goo MJ; Ghim SG; Hong IH; Kim AY; Jeon SM; Choi MS; Elfadl AK; Chung MJ; Lee EJ; Kim YD; Kim JH; Kim SY; Jeong KS
    Int J Rheum Dis; 2018 Mar; 21(3):620-628. PubMed ID: 29205898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 13-week oral toxicity study of prulifloxacin (NM441) in rats followed by a 5-week recovery test].
    Ishibashi S; Nakazawa M; Tawaratani T; Uchimoto H; Yoshida M; Iwakura K; Sumi N; Shindo Y
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():89-111. PubMed ID: 8709171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone.
    Burkhardt JE; Hill MA; Turek JJ; Carlton WW
    Vet Pathol; 1992 May; 29(3):230-8. PubMed ID: 1621334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 13-week oral toxicity study of prulifloxacin (NM441) in dogs followed by a 5-week recovery test].
    Yoshida M; Kawaminami A; Tawaratani T; Uchimoto H; Ishibashi S; Iwakura K; Sumi N; Shindo Y
    J Toxicol Sci; 1996 Jun; 21 Suppl 1():113-29. PubMed ID: 8709156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cartilage degradation and suppression of PGE
    Akhtar N; Khan NM; Ashruf OS; Haqqi TM
    Nutrition; 2017 Jan; 33():1-13. PubMed ID: 27908544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis.
    Tiraloche G; Girard C; Chouinard L; Sampalis J; Moquin L; Ionescu M; Reiner A; Poole AR; Laverty S
    Arthritis Rheum; 2005 Apr; 52(4):1118-28. PubMed ID: 15818693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.